MYFENAX

This brand name is authorized in Austria, Croatia, Cyprus, Estonia, Finland, Germany, Hong Kong SAR China, Ireland, Italy, Lithuania, Netherlands, Poland, Singapore, Spain, UK.

Active ingredients

The drug MYFENAX contains one active pharmaceutical ingredient (API):

1	Mycophenolate mofetil UNII 9242ECW6R0 - MYCOPHENOLATE MOFETIL
	Mycophenolate mofetil is the 2-morpholinoethyl ester of mycophenolic acid (MPA). MPA is a potent, selective, uncompetitive and reversible inhibitor of inosine monophosphate dehydrogenase, and therefore inhibits the de novo pathway of guanosine nucleotide synthesis without incorporation into DNA.
	Read more about Mycophenolate mofetil

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L04AA06	Mycophenolic acid	L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AA Selective immunosuppressants
Discover more medicines within L04AA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	06560131, 06560148, 06560154, 06560160, 10764543, 11330999, 11331007, 11367488, 11854001, 14131964, 14162083, 15306590, 16134033, 16530674, 17165024
EE	Ravimiamet	1343258, 1343269, 1343270, 1343281, 1833443
ES	Centro de información online de medicamentos de la AEMPS	107438005, 107438006
FI	Lääkealan turvallisuus- ja kehittämiskeskus	055073, 055084
GB	Medicines & Healthcare Products Regulatory Agency	181640, 181642
HK	Department of Health Drug Office	58339, 58340
IE	Health Products Regulatory Authority	88532, 88533
IT	Agenzia del Farmaco	039696012, 039696036
LT	Valstybinė vaistų kontrolės tarnyba	1004992, 1005358, 1032553, 1032554, 1060780, 1060781, 1089905, 1089906, 1090795, 1090796
NL	Z-Index G-Standaard, PRK	44369
PL	Rejestru Produktów Leczniczych	100190813, 100190820
SG	Health Sciences Authority	13986P